Improved Survival, Quality of Life, and Quality-Adjusted Survival in Breast Cancer Patients Treated With Efaproxiral (Efaproxyn) Plus Whole-Brain Radiation Therapy for Brain Metastases

200775 citationsJournal Article

Authors

Charles Scott · Air Squared (United States)

Baldassarre Stea · University of Arizona

Abdenour Nabid · Centre Hospitalier Universitaire de Sherbrooke

Abstract

Survival, quality of life, and quality-adjusted survival were all improved in breast cancer patients with brain metastases receiving efaproxiral and WBRT compared with those receiving WBRT alone.

Topics & Keywords

Brain Metastases and Treatment Lung Cancer Research Studies Glioma Diagnosis and Treatment

Publication Details

Published in: American Journal of Clinical Oncology

Volume 30, Issue 6, pp. 580-587

DOI: 10.1097/coc.0b013e3180653c0d

Field-Weighted Citation Impact: 4.04

Command Palette

Improved Survival, Quality of Life, and Quality-Adjusted Survival in Breast Cancer Patients Treated With Efaproxiral (Efaproxyn) Plus Whole-Brain Radiation Therapy for Brain Metastases

Authors

Abstract

Topics & Keywords

Publication Details